Unlocking Health Technology’s Potential for All
One big lesson from the COVID-19 pandemic was that mRNA technologies will not realize their full potential unless we adopt an approach that puts equitable access and the common good first. That means fundamentally changing how we think about public-private partnerships and intellectual property in the health-care domain.
LONDON – COVID-19 cases are on the rise again, offering a stark reminder of the lessons we ought to have learned from previous waves. Far from being confined to COVID, most of these lessons apply to infectious-disease threats generally.